Prestige Consumer Healthcare (NYSE:PBH) Stock Price Down 10% After Earnings Miss

Key Points

• Prestige Consumer Healthcare's share price plummeted 10% on Thursday, reaching a low of $66.74, significantly lower than the previous closing price of $75.16.
• Analysts have mixed views on the stock, with four giving it a buy rating and three a hold rating, resulting in an average target price of $93.33.
• The company's recent earnings report showed a revenue increase of 7.0% year-over-year, with an EPS of $1.32, exceeding analyst expectations.

Prestige Consumer Healthcare Inc. (NYSE:PBH - Get Free Report) traded down 10% during mid-day trading on Thursday following a dissappointing earnings announcement. The company traded as low as $66.74 and last traded at $67.67. 66,096 shares changed hands during mid-day trading, a decline of 82% from the average session volume of 365,909 shares. The stock had previously closed at $75.16.

The company reported $0.95 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.01 by ($0.06). The firm had revenue of $249.53 million during the quarter, compared to analysts' expectations of $260.71 million. Prestige Consumer Healthcare had a return on equity of 12.69% and a net margin of 19.02%. Prestige Consumer Healthcare's revenue for the quarter was down 6.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.90 earnings per share.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on PBH shares. Canaccord Genuity Group dropped their target price on Prestige Consumer Healthcare from $105.00 to $100.00 and set a "buy" rating for the company in a report on Friday. Wall Street Zen cut Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a report on Saturday. Finally, Royal Bank Of Canada raised Prestige Consumer Healthcare to a "hold" rating in a research report on Thursday, May 8th. Four research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $93.33.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Kayne Anderson Rudnick Investment Management LLC raised its position in shares of Prestige Consumer Healthcare by 45.3% in the 1st quarter. Kayne Anderson Rudnick Investment Management LLC now owns 1,580,819 shares of the company's stock worth $135,903,000 after acquiring an additional 493,199 shares in the last quarter. Geode Capital Management LLC raised its position in shares of Prestige Consumer Healthcare by 0.7% in the 2nd quarter. Geode Capital Management LLC now owns 1,413,041 shares of the company's stock worth $112,843,000 after acquiring an additional 9,455 shares in the last quarter. Invesco Ltd. raised its position in shares of Prestige Consumer Healthcare by 24.7% in the 1st quarter. Invesco Ltd. now owns 1,321,800 shares of the company's stock worth $113,635,000 after acquiring an additional 261,537 shares in the last quarter. Congress Asset Management Co. raised its position in shares of Prestige Consumer Healthcare by 1.8% in the 2nd quarter. Congress Asset Management Co. now owns 1,009,595 shares of the company's stock worth $80,616,000 after acquiring an additional 18,015 shares in the last quarter. Finally, Westwood Holdings Group Inc. raised its position in shares of Prestige Consumer Healthcare by 2.4% in the 2nd quarter. Westwood Holdings Group Inc. now owns 881,908 shares of the company's stock worth $70,420,000 after acquiring an additional 20,626 shares in the last quarter. Institutional investors own 99.95% of the company's stock.

Prestige Consumer Healthcare Price Performance

The stock has a market cap of $3.15 billion, a P/E ratio of 15.03, a price-to-earnings-growth ratio of 1.98 and a beta of 0.43. The firm has a 50-day moving average price of $78.83 and a 200-day moving average price of $82.00. The company has a debt-to-equity ratio of 0.55, a quick ratio of 2.99 and a current ratio of 4.38.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.